Skip to main content

Table 7 Multivariate analyses of clinical and tumor factors associated with Epcam in 39 HCC patients

From: Impact of stem cell marker expression on recurrence of TACE-treated hepatocellular carcinoma post liver transplantation

Variable P value OR 95%CI
Differentiation (well/moderate/poor) 0.056 5.01 0.96-26.21
TACE Treatment/not 0.025 5.88 1.25-27.80